newsroompost
  • youtube
  • facebook
  • twitter
  1. Home

  2. Tag: Covaxin

Centre places orders for 25 crore doses of Covishield, 19 crore Covaxin doses

Centre places orders for 25 crore doses of Covishield, 19 crore Covaxin doses

 Newsroom Staff
Centre places orders for 44 crore doses of Covishield & Covaxin

Centre places orders for 44 crore doses of Covishield & Covaxin

 Newsroom Staff
Central Govt.: States/UTs will be provided Adequate Vaccine supply as per consumption

Central Govt.: States/UTs will be provided Adequate Vaccine supply as per consumption

 Newsroom Staff
Delhi HC refuses to put stay on Phase 2-3 clinical trials of Covaxin for 2-18 age group

Delhi HC refuses to put stay on Phase 2-3 clinical trials of Covaxin for 2-18 age group

 ANI
Covaxin phase II/III clinical trials for 2-18 age group to begin in 10-12 days: Govt

Covaxin phase II/III clinical trials for 2-18 age group to begin in 10-12 days: Govt

 Newsroom Staff
‘World is in vaccine apartheid’, says WHO Chief

‘World is in vaccine apartheid’, says WHO Chief

 ANI
Gap between 2 doses of Covishield to be 12-16 weeks, Health Ministry gives nod

Gap between 2 doses of Covishield to be 12-16 weeks, Health Ministry gives nod

 ANI
Dead bodies found buried in sand near river Ganga in UP’s Unnao

Dead bodies found buried in sand near river Ganga in UP’s Unnao

 Newsroom Staff
Politics over Covaxin: Sisodia claims Bharat Biotech ‘denied’ vaccine to Delhi, co-founder says dispatched it on May 10

Politics over Covaxin: Sisodia claims Bharat Biotech ‘denied’ vaccine to Delhi, co-founder says dispatched it on May 10

 Newsroom Staff
Vaccine jabs for 2-18 year old soon? Covaxin cleared to conduct clinical trials

Vaccine jabs for 2-18 year old soon? Covaxin cleared to conduct clinical trials

 Newsroom Staff

What's New

Don't Miss

newsroompost

About Us

This site is run and owned by Headlong NewsroomPost India Private Limited.

Quick Link

 

Important Link

© 2024, All Rights Reserved by Headlong Newsroom Post India Private Limited